Found: 22
Select item for more details and to access through your institution.
Pancreatic cancer survival analysis defines a signature that predicts outcome.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0201751
- By:
- Publication type:
- Article
Nonoperative Rectal Cancer Management With Short-Course Radiation Followed by Chemotherapy: A Nonrandomized Control Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The MK2/Hsp27 axis is a major survival mechanism for pancreatic ductal adenocarcinoma under genotoxic stress.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 622, p. 1, doi. 10.1126/scitranslmed.abb5445
- By:
- Publication type:
- Article
Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer.
- Published in:
- Signal Transduction & Targeted Therapy, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41392-020-00341-1
- By:
- Publication type:
- Article
Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. e115, doi. 10.1093/oncolo/oyac237
- By:
- Publication type:
- Article
A Case of a Pathological Complete Response to Neoadjuvant Nivolumab plus Ipilimumab in Periampullary Adenocarcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 722, doi. 10.1002/onco.13821
- By:
- Publication type:
- Article
Neoadjuvant Therapy of Pancreatic Cancer: The Emerging Paradigm?
- Published in:
- Oncologist, 2012, v. 17, n. 2, p. 192, doi. 10.1634/theoncologist.2011-0268
- By:
- Publication type:
- Article
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25177-3
- By:
- Publication type:
- Article
Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for patients with advanced, inoperable pancreatic adenocarcinoma: a phase 1b observational study.
- Published in:
- Cancer & Metabolism, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40170-023-00306-2
- By:
- Publication type:
- Article
RALA and RALBP1 regulate mitochondrial fission at mitosis.
- Published in:
- Nature Cell Biology, 2011, v. 13, n. 9, p. 1108, doi. 10.1038/ncb2310
- By:
- Publication type:
- Article
Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 2, p. 68, doi. 10.1177/1758834014564775
- By:
- Publication type:
- Article
TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Induction of cancer neoantigens facilitates development of clinically relevant models for the study of pancreatic cancer immunobiology.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2813, doi. 10.1007/s00262-023-03463-x
- By:
- Publication type:
- Article
Spliceman—a computational web server that predicts sequence variations in pre-mRNA splicing.
- Published in:
- Bioinformatics, 2012, v. 28, n. 7, p. 1031, doi. 10.1093/bioinformatics/bts074
- By:
- Publication type:
- Article
Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17093-9
- By:
- Publication type:
- Article
Evolving Paradigms in the Systemic Treatment of Advanced Gallbladder Cancer: Updates in Year 2022.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1249, doi. 10.3390/cancers14051249
- By:
- Publication type:
- Article
Oncogenic KRAS -Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5481, doi. 10.3390/cancers13215481
- By:
- Publication type:
- Article
Phospho-Ser 784 -VCP Drives Resistance of Pancreatic Ductal Adenocarcinoma to Genotoxic Chemotherapies and Predicts the Chemo-Sensitizing Effect of VCP Inhibitor.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5076, doi. 10.3390/cancers13205076
- By:
- Publication type:
- Article
Combined Systemic and Hepatic Artery Infusion Pump Chemo-Therapy as a Liver-Directed Therapy for Colorectal Liver Metastasis-Review of Literature and Case Discussion.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1283, doi. 10.3390/cancers13061283
- By:
- Publication type:
- Article
Deciphering the Role of Innate Immune NF-ĸB Pathway in Pancreatic Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2675, doi. 10.3390/cancers12092675
- By:
- Publication type:
- Article
Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.
- Published in:
- Immunological Reviews, 2012, v. 246, n. 1, p. 359, doi. 10.1111/j.1600-065X.2012.01105.x
- By:
- Publication type:
- Article